Therapeutic processes and clinical outcomes of body psychotherapy in chronic schizophrenia - An open clinical trial

Arts in Psychotherapy

Volumn 38, Issue 3, 2011, Pages 196-203

  Röhricht, Frank ^a,b   Papadopoulos, Nina ^a   Holden, Sarah ^c   Clarke, Tom ^d   Priebe, Stefan ^e  

^a EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF ESSEX   (United Kingdom)

^c Consultant Movement Psychotherapist in Private Practice ^*  (United Kingdom)

^d KINGSTON UNIVERSITY   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Body psychotherapy; Dance movement therapy; Negative symptoms; Schizophrenia; Therapeutic processes

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; BLUNTED AFFECT; BODY PSYCHOTHERAPY; BRIEF PSYCHIATRIC RATING SCALE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DIFFERENTIAL EMOTIONS SCALE; EMOTIONALITY; FEMALE; GROUP THERAPY; HUMAN; INTENTION TO TREAT ANALYSIS; MALE; MANCHESTER SHORT ASSESSMENT OF QUALITY OF LIFE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; OBSERVATIONAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; PSYCHOTHERAPY; QUALITATIVE RESEARCH; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL FUNCTIONING SCALE; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY;

EID: 79960339659     PISSN: 01974556     EISSN: 18735878     Source Type: Journal    
DOI: 10.1016/j.aip.2011.06.001     Document Type: Article

References (38)

1. Addington J., Addington D. Social and cognitive functioning in psychosis. Schizophrenia Research 2008, 99:176-181. (Epub 2007 August 2).
2. Berenbaum H., Oltmanns T.F. Emotional experience and expression in schizophrenia and depression. Journal of Abnormal Psychology 1992, 101:37-44.
3. Birchwood M., Smith J., Cochrane R., Wetton S., Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry 1990, 157:853-859.
4. Bouricius J. Negative symptoms and emotions in schizophrenia. Schizophrenia Bulletin 1989, 15:201-208.
5. Brosan L., Reynolds S., Moore R.G. Self-evaluation of cognitive therapy performance: Do therapists know how competent they are?. Behavioural and Cognitive Psychotherapy 2008, 36:581-587.
6. Chakos M., Lieberman J., Hoffman E., Bradford D., Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials. American Journal of Psychiatry 2001, 158:518-526.
7. Dimic S., Wildgrube C., McCabe R., Hassan I., Barnes T.R., Priebe S. Non-verbal behaviour of patients with schizophrenia in medical consultations - A comparison with depressed patients and association with symptom levels. Psychopathology 2010, 43:216-222. (Epub 2010 April 28).
8. Exner C., Boucsein K., Degner D., Irle E., Weniger G. Impaired emotional learning and reduced amygdala size in schizophrenia: A 3-month follow-up. Schizophrenia Research 2004, 71:493-503.
9. Guimon J. The body in psychotherapy 1997, Karger, Basel.
10. Izard C.E., Libero D.Z., Putnam P., Haynes O.M. Stability of emotion experiences and their relations to traits of personality. Journal of Personality and Social Psychology 1993, 64:847-860.
11. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
12. Kring A.M., Neale J. Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion?. Journal of Abnormal Psychology 1996, 105:249-257.
13. Lapierre Y.D., Angus C., Awad A.G., Saxena B.M., Jones B., Williamson P., et al. The treatment of negative symptoms: A clinical and methodological study. International Journal of Clinical Psychopharmacology 1999, 14:101-112.
14. Leifker F.R., Bowie C.R., Harvey P.D. The determinants of everyday outcomes in schizophrenia: Influences of cognitive impairment, clinical symptoms, and functional capacity. Schizophrenia Research 2009, 115:82-87.
15. Leucht S., Pitschel-Walz G., Abraham D., Kissling W. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophrenia Research 1999, 35:51-68.
16. Liddle P.F. Descriptive clinical features of schizophrenia. New Oxford Textbook of Psychiatry 2000, Vol. 1:571-576. Oxford University Press, New York.
17. Loew T., Tritt K., Lahmann C., Röhricht F. Körperpsychotherapien - wissenschaftlich begründet? Eine Übersicht über empirisch evaluierte Körperpsychotherapieverfahren. Psychodynamische Psychotherapie 2006, 5:6-19.
18. Maggini C., Raballo A. Self-centrality, basic symptoms model and psychopathology in schizophrenia. Psychopathology 2004, 37:69-75.
19. National Institute for Health and Clinical Excellence (NICE) (2009). Guidelines for the treatment of schizophrenia (update, March 2009). http://www.nice.org.uk/nicemedia/live/11786/43608/43608.pdf.
20. Pérez-Álvarez M., García-Montes J.M., Vallina-Fernández O., Perona-Garcelán S., Cuevas-Yust C. New life for schizophrenia psychotherapy in the light of phenomenology. Clinical Psychology & Psychotherapy 2010, July 30 (Epub ahead of print).
21. Priebe S., Huxley P., Knight S., Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry 1999, 45:7-12.
22. Rector N.A., Seeman M.V., Segal Z.V. Cognitive therapy for schizophrenia: A preliminary randomized controlled trial. Schizophrenia Research 2003, 63:1-11.
23. Röhricht F. Körperorientierte Psychotherapie psychischer Störungen - Ein Leitfaden für Forschung und Praxis 2000, Hogrefe, Göttingen-Bern-Toronto-Seattle.
24. Röhricht F. Body oriented psychotherapy - The state of the art in empirical research and evidence based practice: A clinical perspective. An International Journal for Theory, Research and Practice - Body, Movement and Dance in Psychotherapy 2009, 4:135-156.
25. Röhricht F., Priebe S. Ego-pathology and common symptom factors in schizophrenia. Journal of Nervous and Mental Disease 2004, 192:446-449.
26. Röhricht F., Priebe S. Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: A randomised controlled trial. Psychological Medicine 2006, 36:669-678.
27. Röhricht F., Papadopoulos N., Suzuki I., Priebe S. Ego-pathology, body experience, and body psychotherapy in chronic schizophrenia. Psychology & Psychotherapy: Theory, Research, and Practice 2009, 82:19-30.
28. Sass L.A., Parnas J. Phenomenology of self-disturbances in schizophrenia: Some research findings and directions. Philosophy, Psychiatry, and Psychology 2001, 8:347-356.
29. Sass L.A., Parnas J. Schizophrenia, consciousness, and the self. Schizophrenia Bulletin 2003, 29:427-444.
30. Slade M., Priebe S. Are randomised controlled trials the only gold that glitters?. British Journal of Psychiatry 2001, 179:286-287.
31. Stanghellini G., Lysaker P.H. The psychotherapy of schizophrenia through the lens of phenomenology: Intersubjectivity and the search for the recovery of first- and second-person awareness. American Journal of Psychotherapy 2007, 61:163-179.
32. Body psychotherapy 2002, Brunner-Routledge, New York. T. Staunton (Ed.).
33. Totton N. Body psychotherapy: An introduction 2003, Open University Press, Maidenhead, Philadelphia.
34. Troisi A., Spalletta G., Pasini A. Non-verbal behaviour deficits in schizophrenia: An ethological study of drug-free patients. Acta Psychiatrica Scandinavica 1998, 97:109-115.
35. Troisi A., Pompili E., Binello L., Sterpone A. Facial expressivity during the clinical interviews as a predictor of functional disability in schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry 2007, 31:475-481.
36. Volavka J., Czobor P., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. American Journal of Psychiatry 2002, 159:255-262.
37. Xia, J., & Grant, T. J. (2009). Dance therapy for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006868 doi:10.1002/14651858.CD006868.pub2.
38. Youngstrom E.A., Green K.W. Reliability generalization of self-report of emotions when using the Differential Emotions Scale. Educational and Psychological Measurement 2003, 63:279-295.